Intranasal administration of TAT-haFGF(14-154) attenuates disease progression in a mouse model of Alzheimer's disease. Neuroscience. 2012; 223:225-237.Lou G, Zhang Q, Xiao F, et al. Intranasal administration of TAT-haFGF14-154 attenuates disease progression in a mouse model of Alzheimer's...
(2012). Intranasal administration of TAT-haFGF14-154 attenuates disease progression in a mouse model of Alzheimer's disease. Neuroscience 223: 225-237.Lou G , Zhang Q , Xiao F , Xiang Q , Su Z , Zhang L , Yang P , et al. 2012 . Intranasal administration of TAT-haFGF((1)(4)(...